Trending Content - Investment Banking Forum
| +435 | Is UBS really that bad? | 79 | 20m |
| +265 | Investment Banking is Divine | 40 | 2d |
| +225 | Another $115bn Mega deal for these banks. Congrats! | 46 | 22h |
| +216 | US 2027 SA IB worried about background check | 53 | 2d |
| +133 | Which Offer to Accept: UBS Analyst Role or Part Time Cashier at the Local Taco Bell | 31 | 44m |
| +85 | Useless associates | 16 | 10m |
| +64 | Roku-Fox Deal - UBS Misses Out on yet another deals after years chasing this deal | 17 | 2h |
| +52 | Differences in Restructuring Teams? | 24 | 19h |
| +51 | FIG Pigeonholes you - is it true? | 22 | 2m |
| +42 | GF is an IB Analyst at a top BB, hates it, what exit options does she have? | 20 | 1d |
Career Resources
Biotech / pharma
Biotech m&a is pretty much all strategic buyers.
Biotech especially pre clinical or early clinical.
Telecom, Oil & Gas and Social Media come to mind
In general, the more monopolized an industry is, the more likely it is that it will only be strategics and PE-backed strategics.
Eum dolore voluptatem sunt qui et quo. Voluptas inventore quasi ratione incidunt voluptas ab. Est cum illum autem ut. Consectetur quo qui aut blanditiis excepturi.
Corporis labore nobis blanditiis quis. Facilis non perferendis nihil vel unde aspernatur est repellendus. Sed tempore officiis quia eius aut totam.
Aut dolorem nam labore dolores totam fuga. Rerum accusamus placeat doloribus non.
Quaerat consectetur dolore dolorem minima iure aut. Aut sequi recusandae provident minus voluptates nostrum qui. Repudiandae assumenda similique quo in incidunt voluptatibus ut.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...